An Overview of Randomised Studies Comparing 5-HT 3 Receptor Antagonists to Conventional Anti-emetics in the Prophylaxis of Acute Chemotherapy-induced Vomiting

By Jantunen I.T.   Kataja V.V.   Muhonen T.T.  

European Journal of Cancer, Vol. 33, Iss. 1, 1997-01 ,pp. : 67-74

Elsevier

Access to resources Recommend Favorite

Receptor occupancy theory-based analysis of antiemetic effects and standard doses of 5-HT₃ receptor antagonists in cancer patients

By Yamada Yasuhiko   Sugiura Munetoshi   Higo Kozue   Ozeki Takeshi   Takayanagi Risa   Okuyama Kiyoshi   Yamamoto Koujirou   Satoh Hitoshi   Sawada Yasufumi   Iga Tatsuji  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 2, 2004-08 ,pp. : 185-190

Springer Publishing Company

Access to resources Recommend Favorite

5-HT 3 Receptor Antagonists: Differences and Similarities

By Roila F.   Ballatori E.   Tonato M.   Del Favero A.  

European Journal of Cancer, Vol. 33, Iss. 9, 1997-08 ,pp. : 1364-1370

Elsevier

Access to resources Recommend Favorite

Factors influencing the prognostic role of oestrogen and progesterone receptor levels in breast cancer-results of the analysis of 670 patients with 11 years of follow-up

By Costa S.-D.   Lange S.   Klinga K.   Merkle E.   Kaufmann M.  

European Journal of Cancer, Vol. 38, Iss. 10, 2002-07 ,pp. : 1329-1334

Elsevier

Access to resources Recommend Favorite

Systematic review of the efficacy of antiemetics in the treatment of nausea in patients with far-advanced cancer

By Glare Paul  

Supportive Care in Cancer, Vol. 12, Iss. 6, 2004-06 ,pp. : 432-440

Springer Publishing Company

Access to resources Recommend Favorite